Community-based eye care is one of Orbis’s top priorities in the country.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
One practice’s experience with office-based surgery validates peer-reviewed study.
Clear communication, transparent priceing, options are key to positive experience
Novel treatments are now shifting paradigm in care of retinal diseases.
Balancing motherhood & ophthalmology: Prioritize family planning, set boundaries, integrate work & personal life. Insights from ophthalmologist-moms.
Panelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Minimizing clinic visits, maximizing use of imaging modalities are key.
Researchers find a strong link between Alzheimer's disease and retinal thinning
Shan Lin, MD, speaks to the new MIGS entering the glaucoma space and providing additional options for patients and providers as they work to preserve vision and work towards a better future for glaucoma treatment options.
Compensation techniques in swept-source optical coherence tomography angiography improve accuracy by correcting signal loss from drusen and other artifacts
In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.
SLT shows promise as treatment for millions of Africans with glaucoma.
Katherine Talcott, MD, a retina specialist at Cleveland Clinic, presented findings on EYP-1901 in the phase 2 DAVIO study.
Details enhance knowledge of biological pathways that contribute to disease pathogenesis.
Ophthalmologists seek methods to control postoperative inflammation.
Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and treatment through advanced imaging technology.
At the Envision Summit 2025 in San Juan, Puerto Rico, Kristen Nwanyanwu, MD, MBA, MHS, joined by her children, discussed her talk on eradicating TRD and the family-friendly environment of the conference.
Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
ZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution.
In ophthalmology, women continue to take on leadership roles and make a difference in the profession.
Using an NSAID to Manage Inflammation and Pain After Cataract Surgery
In observance of International Holocaust Remembrance Day this January 27, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.
Experts discuss the use of steroids, particularly in the context of diabetic macular edema (DME). The inflammatory nature of DME reveals the effectiveness of steroids, especially in cases where persistent fluid remains despite anti-VEGF treatment.
Technology offers accessibility, scalability to countries where care is needed the most.
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
At the Envision Summit 2025 in San Juan, Puerto Rico, Ollya Fromal, MD, gave advice on how retina specialists can manage add-ons in their busy retina clinics.
Aggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.